CONTROLLED-RELEASE LEVODOPA CARBIDOPA .1. SINEMET CR3 TREATMENT OF RESPONSE FLUCTUATIONS IN PARKINSONS-DISEASE

被引：47

作者：

CEDARBAUM, JM ^{[1
]}

BRECK, L ^{[1
]}

KUTT, H ^{[1
]}

MCDOWELL, FH ^{[1
]}

机构：

[1] CORNELL UNIV,MED CTR,NEW YORK HOSP,NEW YORK,NY 10021

来源：

NEUROLOGY | 1987年 / 37卷 / 02期

关键词：

D O I：

10.1212/WNL.37.2.233

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：233 / 241

页数：9

共 38 条

[1]

[Anonymous], 1982, MOVEMENT DISORD

[2]

BARTHOLINI G, 1979, BR J PHARM, V40, P461

[3] [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY [J].

BOKOBZA, B ;

RUBERG, M ;

SCATTON, B ;

JAVOYAGID, F ;

AGID, Y .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) :167-175

[4] EFFECT OF SUPPLEMENTAL CARBIDOPA ON BIOAVAILABILITY OF L-DOPA [J].

CEDARBAUM, JM ;

KUTT, H ;

DHAR, AK ;

WATKINS, S ;

MCDOWELL, FH .

CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) :153-159

[5]

Clough C G, 1984, Adv Neurol, V40, P131

[6]

CURZON G, 1973, LANCET, V1, P781

[7] DOUBLE-BLIND TRIAL OF PERGOLIDE FOR PARKINSONS-DISEASE [J].

DIAMOND, SG ;

MARKHAM, CH ;

TRECIOKAS, LJ .

NEUROLOGY, 1985, 35 (03) :291-295

[8]

ECKSTEIN B, 1973, LANCET, V1, P431

[9]

ERICKSSON T, 1984, J NEURAL TRANSM, V59, P229

[10] ON-OFF FLUCTUATIONS IN PARKINSONS-DISEASE - A CLINICAL AND NEURO-PHARMACOLOGICAL STUDY [J].

HARDIE, RJ ;

LEES, AJ ;

STERN, GM .

BRAIN, 1984, 107 (JUN) :487-506

← 1 2 3 4 →